Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Drug Manufacturers Adverse Event Reports Submited to FDA Often Incomplete: ISMP February 3, 2015 Irvin Jackson Add Your Comments According to an independent analysis of adverse drug event reports filed with federal regulators, many pharmaceutical companies provide incomplete information about the injury or harm that may have been caused by side effects of their medications. The Institute for Safe Medication Practices (ISMP) published its most recent QuarterWatch report (PDF) on January 28, reviewing reports filed with the U.S. Food and Drug Administration’s Adverse Event Reporting System (FAERS) between the fourth quarter of 2013 and the first quarter of 2014. The report criticizes the current system, calling for an update to rules on submitting adverse event reports in the face of chronic incomplete filings by drug makers. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “Our conclusion: it seems clear that this drug safety monitoring system is in need of modernization,” the report states. “It suffers from a flood of low quality reports from drug manufacturers and has not yet been updated for the changing environment in which drugs are marketed to health professionals and consumers.” The FAERS is a surveillance system for post marketing drug side effects. While consumers and health care professionals can voluntarily file reports, manufacturers are legally required to do so whenever they receive information about an injury or problems associated with one of their medications. Most of FDA warnings issued about potential drug side effects come as a result of reports filed with FAERS, and the U.S. agency relies on the information to make regulatory decisions that may have severe financial impacts on the manufacturers. The vast majority of reports, more than 95%, come from manufacturers after they receive complaints of problems from doctors and patients. However, ISMP found that most of those reports were of poor quality. ISMP indicates that 44% of the reports filed did not indicate when the incident took place, another 36% did not include the age of the patient, and just under 50% had all of the basic information, including age, gender and an event date. In nearly 30% of the reports filed involving patient deaths, manufacturers failed to tell the FDA whether the drug was suspected of contributing to the fatality. The ISMP notes that the FDA’s guidance on submitting reports has not been updated since 2001, and says an update is sorely overdue. One drug the report looked at involved the new hepatitis C drug Sovaldi (sofosbuvir), which is manufactured by Gilead Pharmaceuticals. The ISMP notes that it is one of a new crop of extremely expensive drugs marketed to a limited number of patients, which generates huge profits for the manufacturer. A standard 2-week Sovaldi treatment course costs $84,000, and Gilead generated in $2.2 billion in revenue during just the first three months the medication was on the market. “Only 39% of sofosbuvir reports were reasonably complete, compared to 71% for Vertex Pharmaceuticals’ competing drug, teaprevir (INCIVEK),” the report notes. “With limited pre-approval testing and weak adverse event reporting, the safety profile of sofosbuvir remains uncertain.” Gilead officials told the ISMP that it adhered to industry standards and said many of the reports it received from sources were incomplete, preventing the company from filing complete FAERS reports. However, the ISMP notes that manufacturer reports are actually less complete than those filed directly by patients and doctors, which are usually the sources for manufacturers’ reports as well. “Modernizing the FDA’s manufacturer adverse event reporting requirements would offer a low-cost opportunity to improve safety surveillance and at the same time either reduce the burden on drug manufacturers or focus existing resources in a more productive direction,” the report concludes. “We can’t think of a good reason why the quality and completeness of serious adverse event reports collected by drug manufacturers is so much worse than those collected online at the FDA. It makes no sense for drug manufacturers to be required to spend millions collecting and submitting adverse drug event reports promptly when so many reports contribute little to the assessment of drug safety.” Tags: Drug Side Effects, Gilead, Sovaldi Image Credit: | More Lawsuit Stories Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” July 3, 2025 Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL July 3, 2025 JAK Inhibitors Could Increase Cancer Risks by as Much as 40%: Study July 3, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)